INCELL
Innovative Life Science Solutions™
Menu
  • Home
    • Contact
    • Close
  • Products
    • My Account
    • Close
  • Reg Med
    • Registrations Licenses & Certifications
    • Cell & Tissue Products
      • Regenerative & Stem Cells
      • Tissue-Derived Products
      • Reagents & Testing
      • INCELL Established Cell Lines
    • Tissue Collections & Kit Products
    • Storage of Cell & Tissue Products
    • Services: Manufacturing , Testing and R&D
      • Accelerated Product Development Services
      • Regenerative & Stem Cell Products
    • Close
  • Micro
    • Microbiology & Vaccine Products
      • Microbiology Testing
        • Sterility: GMP and USP Compliant
        • Microbial Bioburden
        • Endotoxin/Pyrogen Testing
        • Mycoplasma Testing
        • Antimicrobial & Microbiological Testing
        • Antimicrobials: New Product Testing In Vivo
    • Vaccines and Microbiology Products
      • Innovative Platforms, Tools and Vaccines
      • Microbiology & Vaccines Collaborations
    • Clinical Studies
    • Close
  • Clinical
    • Clinical Trials
    • Personalized Medicine
    • Close
  • About
    • Corporate
      • History
      • Mission
      • Registration, Licenses & Certificates
      • Memberships, Boards and Committees
    • Organization & Management
      • Board Members
        • Executive Managers
      • Key Alliances
        • Collaborative Business Model
    • Business Units & Activities
      • Regenerative Medicine
      • Media, Solutions & Kits
      • Microbiology & Vaccine Products
      • 503B Compounding & Formulation
    • Close
  • News
    • Close

Mary Pat Moyer, PhD, CTBS, Founder, CEO and Chief Science Officer

Published on: February 26, 2016 | Author: INCELL Online Team

 Mary Pat Moyer, PhD, CTBS, Founder, CEO and Chief Science OfficerDr. Moyer brings over 4 decades of broad-ranging expertise, knowledge, integrity and leadership to INCELL’s regenerative medicine, cell and tissue therapies, and infectious diseases programs, and to the product development and manufacturing of biologics, devices and drugs. Dr. Moyer has a Ph.D. in Microbiology (Univ. Texas at Austin, 1981) and is an elected member of the American Academy for Microbiology. Previously a University of Texas Health Science Center at San Antonio tenured Professor, Surgical Research Division Head, Director of the Center for Human Cell Biotechnology, and appointed faculty member of 5 departments (1981-2001), Moyer is currently an adjunct Professor. She has consulted for many companies and served local, state, national and international entities, including NIH, WHO, FDA, FMDIC, NASA, US State Dept., TWIC, BioMedSA, ICID, and more. Moyer has received many grants, contracts and awards of recognition for leadership as a scientist, entrepreneur, STEM educator and life sciences technology community activist. Her awards include the international Athena Award, EY Entrepreneur of the Year, Texas Healthcare and Biosciences Institute “Top Ten Texas CEOs in Life Sciences”, American Association of University Women (AAUW) “Breaking the Glass Ceiling Award”, and many more.

Categories: | Tags: No tags |
« Lynn Miller, CTBS, Quality Assurance Manager
Kim Saeger, MHA, CTBS, HR Manager »

Follow Us

Recent Posts

  • INCELL Price Changes
  • Dr. Mary Pat Moyer inducted to the National Academy of Engineering for her contribution to regenerative medicine, October 2019
  • Dr. Moyer Addresses Orthopedic Physicians at AAOM National Meeting
  • INCELL Global Expansion
  • INCELL Sponsors WSCS in December 2016

Contact INCELL Corporation LLC

12734 Cimarron Path (Directions)
San Antonio, Texas 78249
Tel: 210-877-0100|Toll-free: 800.364.1765
Fax: 210-877-0200

Privacy | Contact

Copyright © 2021. All Rights Reserved.

Designed by WebAuthorings.